Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$26.50
0.491.88%
À la fermeture: -
$26.38
-0.12-0.45%
Après les heures de négociation: 5:37 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Bath & Body Works Corp a un objectif de cours consensuel de 567,61 $ basé sur les notes de 38 analystes. Le plus haut est de 1 350 $ émis par HSBC le 10 mai 2024<. Le plus bas est de 100 $ émis par Deutsche Bank le 5 août 2024. Les 3 dernières notations d'analystes ont été publiées par New Street Research, Goldman Sachs et Deutsche Bank respectivement le 6 août 2024, le 5 août 2024 et le 5 août 2024. Avec un objectif de cours moyen de 118,33 $ entre New Street Research, Goldman Sachs et Deutsche Bank, il existe une hausse implicite de 0,21 % pour Bath & Body Works Corp à partir de ces notations d'analystes les plus récentes.
Sociétés d'analyse émettant des recommandations1
Jefferies
JP Morgan
Morgan Stanley
UBS
Barclays
1calculé à partir des notes des analystes
Notes d'analystes pour Bath & Body Works
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/14/2025 | — | Jefferies | $32 → $28.5 | Maintains | Hold | |||
10/06/2025 | — | JP Morgan | → $26 | Downgrade | Overweight → Neutral | |||
09/12/2025 | — | Morgan Stanley | $41 → $40 | Maintains | Overweight | |||
08/29/2025 | — | UBS | $36 → $32 | Maintains | Neutral | |||
08/29/2025 | — | Barclays | $30 → $32 | Maintains | Equal-Weight | |||
08/28/2025 | — | Telsey Advisory Group | $38 → $38 | Maintains | Outperform | |||
08/21/2025 | — | Telsey Advisory Group | $38 → $38 | Maintains | Outperform | |||
08/19/2025 | — | Citigroup | $42 → $40 | Maintains | Buy | |||
07/28/2025 | — | JP Morgan | $40 → $46 | Maintains | Overweight | |||
05/30/2025 | — | Barclays | $35 → $30 | Maintains | Equal-Weight | |||
05/30/2025 | — | Goldman Sachs | $44 → $43 | Maintains | Buy | |||
05/30/2025 | — | Telsey Advisory Group | $43 → $38 | Maintains | Outperform | |||
05/29/2025 | — | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
05/20/2025 | — | Citigroup | $36 → $42 | Maintains | Buy | |||
05/20/2025 | — | UBS | $32 → $36 | Maintains | Neutral | |||
05/20/2025 | — | Barclays | $31 → $35 | Maintains | Equal-Weight | |||
05/20/2025 | — | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
05/19/2025 | — | JP Morgan | $41 → $43 | Maintains | Overweight | |||
05/14/2025 | — | Wells Fargo | $40 → $44 | Maintains | Overweight | |||
05/12/2025 | — | Barclays | $38 → $31 | Maintains | Equal-Weight | |||
05/06/2025 | — | Morgan Stanley | $49 → $43 | Maintains | Overweight | |||
04/30/2025 | — | Wells Fargo | $48 → $40 | Maintains | Overweight | |||
04/22/2025 | — | Goldman Sachs | $49 → $42 | Maintains | Buy | |||
04/17/2025 | — | Raymond James | $46 → $37 | Maintains | Outperform | |||
04/14/2025 | — | JP Morgan | $47 → $41 | Maintains | Overweight | |||
04/09/2025 | — | Piper Sandler | $38 → $35 | Upgrade | Neutral → Overweight | |||
04/07/2025 | — | Citigroup | $48 → $36 | Maintains | Buy | |||
03/03/2025 | — | Barclays | $43 → $38 | Maintains | Equal-Weight | |||
02/28/2025 | — | UBS | $42 → $39 | Maintains | Neutral | |||
02/28/2025 | — | Baird | $45 → $47 | Maintains | Outperform | |||
02/28/2025 | — | Citigroup | $40 → $48 | Upgrade | Neutral → Buy | |||
02/28/2025 | — | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
02/27/2025 | — | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
02/25/2025 | — | Raymond James | $42 → $46 | Reiterates | Outperform → Outperform | |||
02/24/2025 | — | Barclays | $34 → $43 | Upgrade | Underweight → Equal-Weight | |||
02/20/2025 | — | Telsey Advisory Group | $43 → $43 | Maintains | Outperform | |||
02/18/2025 | — | JP Morgan | $41 → $47 | Upgrade | Neutral → Overweight | |||
01/24/2025 | — | JP Morgan | $39 → $41 | Maintains | Neutral | |||
01/10/2025 | — | Argus Research | — | Maintains | Hold | |||
01/10/2025 | — | Wells Fargo | $42 → $48 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | — | Piper Sandler | $36 → $39 | Maintains | Neutral | |||
12/12/2024 | — | TD Cowen | $42 → $48 | Maintains | Buy | |||
12/12/2024 | — | Wells Fargo | $38 → $42 | Maintains | Equal-Weight | |||
11/26/2024 | — | UBS | $38 → $40 | Maintains | Neutral | |||
11/26/2024 | — | TD Cowen | $40 → $42 | Maintains | Buy | |||
11/26/2024 | — | Telsey Advisory Group | $42 → $43 | Maintains | Outperform | |||
11/26/2024 | — | Morgan Stanley | $48 → $49 | Maintains | Overweight | |||
11/26/2024 | — | Deutsche Bank | $51 → $52 | Maintains | Buy | |||
11/26/2024 | — | Wells Fargo | $32 → $38 | Maintains | Equal-Weight | |||
11/26/2024 | — | JP Morgan | $35 → $39 | Maintains | Neutral | |||
11/26/2024 | — | Barclays | $28 → $34 | Maintains | Underweight | |||
11/26/2024 | — | Piper Sandler | $35 → $36 | Maintains | Neutral | |||
11/25/2024 | — | Telsey Advisory Group | $42 → $42 | Maintains | Outperform | |||
11/18/2024 | — | Telsey Advisory Group | $42 → $42 | Maintains | Outperform | |||
11/08/2024 | — | Barclays | $31 → $28 | Downgrade | Equal-Weight → Underweight | |||
11/06/2024 | — | Wells Fargo | $35 → $32 | Maintains | Equal-Weight | |||
09/26/2024 | — | Telsey Advisory Group | $42 → $42 | Maintains | Outperform | |||
09/05/2024 | — | Morgan Stanley | $56 → $51 | Maintains | Overweight | |||
08/29/2024 | — | Telsey Advisory Group | $53 → $42 | Maintains | Outperform | |||
08/29/2024 | — | BMO Capital | $52 → $50 | Reiterates | Outperform → Outperform | |||
08/29/2024 | — | Goldman Sachs | $60 → $49 | Maintains | Buy | |||
08/29/2024 | — | JP Morgan | $42 → $39 | Maintains | Neutral | |||
08/29/2024 | — | Raymond James | $51 → $42 | Maintains | Outperform | |||
08/29/2024 | — | Barclays | $32 → $31 | Maintains | Equal-Weight | |||
08/29/2024 | — | UBS | $52 → $38 | Maintains | Neutral | |||
08/29/2024 | — | B of A Securities | $54 → $45 | Maintains | Buy | |||
08/29/2024 | — | Baird | $54 → $45 | Maintains | Outperform | |||
08/28/2024 | — | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
08/28/2024 | — | Evercore ISI Group | $45 → $35 | Maintains | In-Line | |||
08/26/2024 | — | Deutsche Bank | $57 → $54 | Maintains | Buy | |||
08/21/2024 | — | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
08/20/2024 | — | Citigroup | $48 → $35 | Maintains | Neutral | |||
08/07/2024 | — | Barclays | $45 → $32 | Maintains | Equal-Weight | |||
07/24/2024 | — | Wells Fargo | $48 → $40 | Maintains | Equal-Weight | |||
07/11/2024 | — | Piper Sandler | $47 → $39 | Maintains | Neutral | |||
06/05/2024 | — | BMO Capital | $50 → $55 | Maintains | Outperform | |||
06/04/2024 | — | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
05/29/2024 | — | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
05/17/2024 | — | JP Morgan | $40 → $53 | Upgrade | Underweight → Neutral | |||
04/24/2024 | — | Wells Fargo | $42 → $48 | Maintains | Equal-Weight | |||
04/09/2024 | — | Piper Sandler | $44 → $45 | Maintains | Neutral | |||
04/05/2024 | — | Telsey Advisory Group | $53 → $53 | Maintains | Outperform | |||
03/04/2024 | — | Goldman Sachs | $49 → $56 | Maintains | Buy | |||
03/04/2024 | — | UBS | $46 → $52 | Maintains | Neutral | |||
03/01/2024 | — | Wells Fargo | $40 → $42 | Maintains | Equal-Weight | |||
03/01/2024 | — | Baird | $50 → $54 | Maintains | Outperform | |||
03/01/2024 | — | BMO Capital | $48 → $50 | Maintains | Outperform | |||
03/01/2024 | — | TD Cowen | $35 → $55 | Maintains | Outperform | |||
03/01/2024 | — | Evercore ISI Group | $30 → $45 | Maintains | In-Line | |||
03/01/2024 | — | Telsey Advisory Group | $50 → $53 | Maintains | Outperform | |||
02/29/2024 | — | Telsey Advisory Group | → $50 | Reiterates | Outperform → Outperform | |||
02/22/2024 | — | Telsey Advisory Group | → $50 | Reiterates | Outperform → Outperform | |||
02/14/2024 | — | UBS | $44 → $46 | Maintains | Neutral | |||
01/04/2024 | — | Barclays | $37 → $45 | Downgrade | Overweight → Equal-Weight | |||
01/02/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
12/22/2023 | — | Wells Fargo | $35 → $40 | Maintains | Equal-Weight | |||
11/17/2023 | — | Evercore ISI Group | $40 → $30 | Maintains | In-Line | |||
11/17/2023 | — | Telsey Advisory Group | $52 → $42 | Maintains | Outperform | |||
10/26/2023 | — | Jefferies | $45 → $30 | Downgrade | Buy → Hold | |||
10/24/2023 | — | JP Morgan | → $27 | Downgrade | Neutral → Underweight |
FAQ
Quel est le cours indicatif de l'action Bath & Body Works (BBWI) ?
Le dernier objectif de prix pour Bath & Body Works (NYSE:BBWI) a été rapporté par Jefferies le octobre 14, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $28.50 s'attendant à ce que BBWI se rise dans les 12 prochains mois (un possible changement de 8.04% upside). 56 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Bath & Body Works (BBWI) ?
La dernière note d'analyste pour Bath & Body Works (NYSE:BBWI) a été fournie par Jefferies, et Bath & Body Works maintenu leur note hold.
Quand a eu lieu la dernière mise à niveau pour Bath & Body Works (BBWI) ?
La dernière amélioration pour Bath & Body Works Inc a eu lieu le avril 9, 2025 lorsque Piper Sandler a augmenté leur objectif de prix à $35. Piper Sandler avait précédemment a neutral pour Bath & Body Works Inc.
Quand a eu lieu la dernière dégradation pour Bath & Body Works (BBWI) ?
La dernière réduction pour Bath & Body Works Inc a eu lieu le octobre 6, 2025 lorsque JP Morgan a changé leur objectif de prix de N/A à $26 pour Bath & Body Works Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Bath & Body Works (BBWI) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Bath & Body Works, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Bath & Body Works a été déposée le octobre 14, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 14, 2026.
La note d'analyste pour Bath & Body Works (BBWI) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Bath & Body Works (BBWI) était un maintenu avec un objectif de prix de $32.00 à $28.50. Le prix actuel de Bath & Body Works (BBWI) est de $26.38, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.